Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Noxopharm Ltd. (AU:NOX)
ASX:NOX
Holding AU:NOX?
Track your performance easily
NOX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.15
Previous CloseAU$0.11
Volume23.25K
Average Volume (3M)307.19K
Market Cap
AU$30.68M
Enterprise ValueAU$16.83M
Total Cash (Recent Filing)AU$14.01M
Total Debt (Recent Filing)AU$160.62K
Price to Earnings (P/E)―
Beta-1.89
Next Earnings
Feb 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. Volume168,811
30 Day Avg. Volume307,186
Standard Deviation0.31
R-Squared0.02
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Noxopharm Ltd. News
PremiumCompany Announcements
Noxopharm Achieves Key Approvals at Annual Meeting
PremiumCompany Announcements
Noxopharm Unveils Strategic Advances and Market Prospects
PremiumCompany Announcements
Noxopharm Advances in Biotech with Promising DevelopmentsPremiumCompany Announcements
Noxopharm Strengthens Cash Reserves with R&D Rebate
PremiumCompany Announcements
Noxopharm Ltd. Announces New Securities Issuance
PremiumCompany Announcements
Noxopharm Secures New Funding with Convertible NotePremiumCompany Announcements
Noxopharm Gains Investor Interest and Expands Drug Trials
PremiumCompany Announcements
Noxopharm Announces Key 2024 AGM DetailsNOX FAQ
What was Noxopharm Ltd.’s price range in the past 12 months?
Noxopharm Ltd. lowest share price was AU$0.05 and its highest was AU$0.15 in the past 12 months.
What is Noxopharm Ltd.’s market cap?
Currently, no data Available
When is Noxopharm Ltd.’s upcoming earnings report date?
Noxopharm Ltd.’s upcoming earnings report date is Feb 20, 2025 which is in 90 days.
How were Noxopharm Ltd.’s earnings last quarter?
Noxopharm Ltd. released its earnings results on Aug 28, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is Noxopharm Ltd. overvalued?
According to Wall Street analysts Noxopharm Ltd.’s price is currently Overvalued.
Does Noxopharm Ltd. pay dividends?
Noxopharm Ltd. does not currently pay dividends.
What is Noxopharm Ltd.’s EPS estimate?
Noxopharm Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Noxopharm Ltd. have?
Noxopharm Ltd. has 292,237,950 shares outstanding.
What happened to Noxopharm Ltd.’s price movement after its last earnings report?
Noxopharm Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of Noxopharm Ltd.?
Currently, no hedge funds are holding shares in AU:NOX
---
Noxopharm Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NOX Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.54%
12-Months-Change
Fundamentals
Return on Equity
-49.12%
Trailing 12-Months
Asset Growth
-33.02%
Trailing 12-Months
Company Description
Noxopharm Ltd.
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.
---
Technical Analysis
Race Oncology Ltd.
―
Vectus Biosystems Limited
―
Hexima Ltd
―
Chimeric Therapeutics Ltd.
―
---